Belfast-based healthtech company Neurovalens announced that it has closed a £2.1 million funding round with existing investors and gained FDA approval for its Modius Stress device, designed to treat anxiety by delivering noninvasive electrical stimulation to the head.

Existing Investors

Neurovalens is a healthtech company based in Belfast, specializing in combining neuroscience and technology to tackle global health challenges. It has developed medical devices designed to deliver noninvasive electrical stimulation to key areas of the brain and nervous system without the need for surgically implanted electrodes.

https://neurovalens.com/

Medical Device

Medical

Biotechnology

Health Care

Belfast, Northern Ireland, United Kingdom

Neurovalens raises £2.1M in funding and gains FDA approval for anxiety treatment wearable device

Investors

Description

Company Information

Related People